Abstract:Objective·To analyze the relationship between the expression level of interferon regulatory factor 3(IRF3)in colorectal cancer and its clinicopathological features and prognosis,and to observe the effects of IRF3 overexpression on the proliferation and invasion ability of colorectal cancer cells and the related protein molecular pathways.Methods The Cancer Genome Atlas(TCGA)data were downloaded and used to analyze the correlation between expression levels of IRF3 and the prognosis of patients(including renal cell carcinoma,colorectal cancer,hepatocellular carcinoma,and prostate cancer).Immunohistochemistry was used to detect the differences in the expression levels of IRF3 between cancerous tissue and adjacent normal tissues of 10 patients with colorectal/renal cancer.The C-terminal residue sites of the IRF3 protein were modified to construct HEK-293T cells overexpressing the phosphorylated IRF3-5D(396/398/402/404/405-D).At 12 and 24 h of cell culture,treatment with TANK-binding kinase 1(TBK1)inhibitor was performed,and Western blotting was used to detect the expression levels of IRF3 and p-IRF3(Ser386)in the cells.RNA sequencing(RNA-seq)was employed to explore the correlation between high expression of IRF3-5D and the expression levels of tumor-related proteins.Colorectal cancer cells CT26 and COLON26 overexpressing wild-type IRF3(IRF3-WT)and IRF3-5D were construct,and cell proliferation and migration ability were assessed by using cell counting,scratch assay,and clonogenic assay.Results·Analysis of TCGA data suggested that the expression level of IRF3 protein in cancer tissues was positively correlated with poor prognosis in patients.Immunohistochemical analysis of pathological tissues from patients with cancer showed that the expression level of IRF3 was significantly upregulated in colorectal cancer tissues and renal cancer tissues,with protein expression concentrated in the cell nucleus.After treatment with TBK1 inhibitors for 12 and 24 h in cell culture,the expression of p-IRF3(Ser386)protein in HEK-293T cells decreased.The results of RNA-seq and Western blotting showed that the expression levels of multiple proteins associated with poor prognosis[such as IRF9,programmed cell death 1-ligand 1(PD-L1),etc.]were significantly upregulated under conditions of high expression of IRF3-5D.Overexpression of IRF3-5D in colorectal cancer cells could significantly enhance the proliferation and migration capabilities of cancer cells.Conclusion·The expression level of IRF3 in colorectal cancer is positively correlated with poor patient prognosis.High expression of IRF3-5D protein in colorectal cancer cells can promote malignant biological behavior of cancer cells.Additionally,IRF3-5D is dependent on the TBK1-mediated activation of the IRF3 activation pathway and upregulates the expression levels of multiple tumor-related proteins.

Increased Igf2bp3 Expression Promotes The Aggressive Phenotypes Of Colorectal Cancer Cells In Vitro And Vivo

Igfbp-Rp1, A Potential Molecule Associated with Colon Cancer Differentiation

IGF2BP3 Promotes the Progression of Colorectal Cancer and Mediates Cetuximab Resistance by Stabilizing EGFR Mrna in an M6a-Dependent Manner

IGF2BP2 promotes the progression of colorectal cancer through a YAP‐dependent mechanism

IGF2BP2 Promotes Colorectal Cancer Progression by Upregulating the Expression of TFRC and Enhancing Iron Metabolism

IGFBP7 plays a potential tumor suppressor role in colorectal carcinogenesis.

PIM3 Functions As Oncogenic Factor and Promotes the Tumor Growth and Metastasis in Colorectal Cancer

IGFBP7 Plays a Potential Tumor Suppressor Role Against Colorectal Carcinogenesis with Its Expression Associated with DNA Hypomethylation of Exon 1

Decreased Expression of IGFBP6 Correlates with Poor Survival in Colorectal Cancer Patients.

TGFBI Protein High Expression Predicts Poor Prognosis in Colorectal Cancer Patients.

IDDF2019-ABS-0290 IGF2BP2 Facilitates Tumor Progression Via an M6a-Dependent Mechanism in Colorectal Carcinoma

IGFBP5 is Upregulated and Associated with Poor Prognosis in Colorectal Cancer

The Oncogenic Functions of Insulin-like Growth Factor 2 mRNA-Binding Protein 3 in Human Carcinomas

IGF2BP3 Overexpression Predicts Poor Prognosis and Correlates with Immune Infiltration in Bladder Cancer

[Knockdown of IGF2BP2 Inhibits Colorectal Cancer Cell Proliferation, Migration and Promotes Tumor Immunity by Down-Regulating MYC Expression].

Epigenetically associated IGF2BP3 upregulation promotes cell proliferation by regulating E2F1 expression in hepatocellular carcinoma

IGF2 loss of imprinting enhances colorectal cancer stem cells pluripotency by promoting tumor autophagy

IGF2BP3 Facilitates Cell Proliferation and Tumorigenesis Via Modulation of JAK/STAT Signalling Pathway in Human Bladder Cancer.

Upregulated Insulin Receptor Tyrosine Kinase Substrate Promotes The Proliferation Of Colorectal Cancer Cells Via The Bfgf/Akt Signaling Pathway

Exploratory study of interferon regulatory factor 3 promoting proliferation and invasion related to colorectal cancer cells

Expression of Insulin-Like Growth Factor- II Mrna-Binding Protein 3 in Colon Cancer and Its Implication